# EDGAR Filing Document

**Accession Number:** 0000053808
**File Stem:** 0000940400-25-002946
**Filing Date:** 2025-9
**Character Count:** 38371
**Document Hash:** 8dcabb4c4ae1703ab0f6bddffe819da9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-25-002946.hdr.sgml**: 20250926

**ACCESSION NUMBER**: 0000940400-25-002946

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250731

**FILED AS OF DATE**: 20250926

**DATE AS OF CHANGE**: 20250926

**PERIOD START**: 20251031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon Investment Funds III
- **CENTRAL INDEX KEY:** 0000053808

**ORGANIZATION NAME:**
- **EIN:** 042694144
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-00524
- **FILM NUMBER:** 251350025

**BUSINESS ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 2129226400

**MAIL ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DREYFUS/LAUREL FUNDS TRUST
- **DATE OF NAME CHANGE:** 20181030

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DREYFUS LAUREL FUNDS TRUST
- **DATE OF NAME CHANGE:** 19941122

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LAUREL FUNDS TRUST
- **DATE OF NAME CHANGE:** 19940202

## Series and Classes Contracts Data

### BNY Mellon Global Equity Income Fund (Series ID: S000018029)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000049945 | Class A      | DEQAX           |
| C000049946 | Class C      | DEQCX           |
| C000049947 | Class I      | DQEIX           |
| C000130468 | Class Y      | DEQYX           |

## Nport-Ex

BNY Mellon Global Equity Income Fund

STATEMENT OF INVESTMENTS

July 31, 2025 (Unaudited)

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Common Stocks — 95.3%** | **Common Stocks — 95.3%** | **Common Stocks — 95.3%** |
| **Brazil — 1.3%** | **Brazil — 1.3%** | **Brazil — 1.3%** |
| B3 SA - Brasil Bolsa Balcao | 1126766 | **2527378** |
| **China — 3.1%** | **China — 3.1%** | **China — 3.1%** |
| NARI Technology Co. Ltd., Cl. A | 945700 | 2876714 |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Cl. A | 96900 | 3114638 |
|  |  | **5991352** |
| **Finland — 1.1%** | **Finland — 1.1%** | **Finland — 1.1%** |
| Fortum OYJ | 119740 | **2198655** |
| **France — 7.6%** | **France — 7.6%** | **France — 7.6%** |
| Cie de Saint-Gobain SA | 32976 | 3774511 |
| Publicis Groupe SA | 35629 | 3260917 |
| Sanofi SA | 46517 | 4185237 |
| Veolia Environnement SA | 106942 | 3624654 |
|  |  | **14845319** |
| **Germany — 7.8%** | **Germany — 7.8%** | **Germany — 7.8%** |
| Deutsche Lufthansa AG | 288060 | 2479970 |
| Deutsche Post AG | 73866 | 3325473 |
| Fresenius SE & Co. KGaA | 74633 | 3575486 |
| Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen | 3765 | 2473133 |
| Siemens AG | 13452 | 3452535 |
|  |  | **15306597** |
| **Hong Kong — 3.9%** | **Hong Kong — 3.9%** | **Hong Kong — 3.9%** |
| AIA Group Ltd. | 532600 | 4979979 |
| Hong Kong Exchanges & Clearing Ltd. | 49700 | 2703427 |
|  |  | **7683406** |
| **Indonesia — 1.3%** | **Indonesia — 1.3%** | **Indonesia — 1.3%** |
| Bank Mandiri Persero Tbk PT | 5377700 | 1473925 |
| Bank Rakyat Indonesia Persero Tbk PT | 4811000 | 1084704 |
|  |  | **2558629** |
| **Ireland — 4.2%** | **Ireland — 4.2%** | **Ireland — 4.2%** |
| Medtronic PLC | 58149 | 5247366 |
| Smurfit WestRock PLC | 66597 | 2955575 |
|  |  | **8202941** |
| **Italy — 2.8%** | **Italy — 2.8%** | **Italy — 2.8%** |
| ENEL SpA | 436203 | 3849448 |
| Moncler SpA | 30725 | 1645874 |
|  |  | **5495322** |
| **Japan — 1.8%** | **Japan — 1.8%** | **Japan — 1.8%** |
| Tokyo Electron Ltd. | 19100 | **3461558** |
| **Mexico — 1.4%** | **Mexico — 1.4%** | **Mexico — 1.4%** |
| Wal-Mart de Mexico SAB de CV | 894031 | **2634939** |
| **Netherlands — 1.9%** | **Netherlands — 1.9%** | **Netherlands — 1.9%** |
| Universal Music Group NV | 127871 | **3703612** |
| **Spain — 2.4%** | **Spain — 2.4%** | **Spain — 2.4%** |
| Industria de Diseno Textil SA | 99623 | **4764738** |
| **Sweden — 2.5%** | **Sweden — 2.5%** | **Sweden — 2.5%** |
| Sandvik AB | 130569 | 3190449 |
| SKF AB, Cl. B | 75918 | 1773624 |
|  |  | **4964073** |

---

**3**

------

*STATEMENT OF INVESTMENTS (Unaudited) (continued)*

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Common Stocks — 95.3% (continued)** | **Common Stocks — 95.3% (continued)** | **Common Stocks — 95.3% (continued)** |
| **Taiwan — 1.3%** | **Taiwan — 1.3%** | **Taiwan — 1.3%** |
| ASE Technology Holding Co. Ltd. | 477000 | **2437139** |
| **United Kingdom — 7.8%** | **United Kingdom — 7.8%** | **United Kingdom — 7.8%** |
| AstraZeneca PLC | 29742 | 4447928 |
| BAE Systems PLC | 157789 | 3759248 |
| Barclays PLC | 666551 | 3268482 |
| GSK PLC | 201139 | 3766693 |
|  |  | **15242351** |
| **United States — 43.1%** | **United States — 43.1%** | **United States — 43.1%** |
| Bristol-Myers Squibb Co. | 56442 | 2444503 |
| C.H. Robinson Worldwide, Inc. | 34645 | 3995261 |
| Cisco Systems, Inc. | 82490 | 5615919 |
| CME Group, Inc. | 24984 | 6952548 |
| Diamondback Energy, Inc. | 27984 | 4160101 |
| Dominion Energy, Inc. | 76400 | 4465580 |
| Exelon Corp. | 90636 | 4073182 |
| Expand Energy Corp. | 24389 | 2555479 |
| First Horizon Corp. | 139791 | 3048842 |
| Gilead Sciences, Inc. | 27426 | 3079666 |
| International Paper Co. | 67244 | 3142985 |
| Johnson & Johnson | 28347 | 4669885 |
| Kenvue, Inc. | 151738 | 3253263 |
| MetLife, Inc. | 40183 | 3051899 |
| Molson Coors Beverage Co., Cl. B | 71336 | 3475490 |
| Omnicom Group, Inc. | 34526 | 2487598 |
| PepsiCo, Inc. | 30272 | 4175114 |
| Phillips 66 | 35290 | 4361138 |
| Starbucks Corp. | 46734 | 4166803 |
| Sysco Corp. | 45015 | 3583194 |
| The Estee Lauder Companies, Inc., Cl. A | 31953 | 2982493 |
| The Kraft Heinz Company | 83996 | 2306530 |
| UnitedHealth Group, Inc. | 8507 | 2123007 |
|  |  | **84170480** |
| &nbsp;&nbsp;&nbsp; **Total Common Stocks** <br>(cost $159,475,905)<br>|  | **186188489** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | |
|:---|:---|:---|:---|
|  | Preferred <br>Dividend <br>Rate (%)<br>|  |  |
| **Preferred Stocks — 2.1%** |  |  |  |
| **South Korea — 2.1%** |  |  |  |
| &nbsp;&nbsp;&nbsp; Samsung Electronics Co. Ltd. <br>(cost $3,172,189)<br>| 2.49 | 100918 | **4191575** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**4**

------

---

| | | | |
|:---|:---|:---|:---|
| Description | 1-Day <br>Yield (%)<br>| Shares | Value ($) |
| **Investment Companies — 2.0%** |  |  |  |
| **Registered Investment Companies — 2.0%** |  |  |  |
| &nbsp;&nbsp;&nbsp; Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional <br> Shares<sup>(a)</sup> <br>(cost $3,893,811)<br>| 4.43 | 3893811 | **3893811** |
| **Total Investments** (cost $166,541,905) |  | **99.4%**<br>| **194273875** |
| **Cash and Receivables (Net)** |  | **.6%**<br>| **1084021** |
| **Net Assets** |  | **100.0%**<br>| **195357896** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> *Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's* *prospectus.*

*See notes to statement of investments.*

**5**

------

Statement of Investments

BNY Mellon Global Equity Income Fund

July 31, 2025 (Unaudited)

The following is a summary of the inputs used as of July 31, 2025 in valuing the fund's investments:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1 -** <br>**Unadjusted** <br>**Quoted Prices**<br>| **Level 2- Other** <br>**Significant** <br>**Observable Inputs**<br>| **Level 3-** <br>**Significant** <br>**Unobservable** <br>**Inputs**<br>| **Total** |
| **Assets ($)** |  |  |  |  |
| Investments in Securities:<sup>†</sup> <br>|  |  |  |  |
| Equity Securities - Common Stocks | &nbsp;&nbsp; 186188489 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **186188489** |
| Equity Securities - Preferred Stocks | &nbsp;&nbsp;&nbsp;&nbsp; 4191575 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **4191575** |
| Investment Companies | &nbsp;&nbsp;&nbsp;&nbsp; 3893811 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **3893811** |
|  | &nbsp;&nbsp; **194273875** | &nbsp;&nbsp; **—** | &nbsp;&nbsp; **—** | &nbsp;&nbsp; **194273875** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>†</sup> *See Statement of Investments for additional detailed categorizations, if any.*

**6**

------

The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") is the exclusive reference of authoritative U.S. generally accepted accounting principles ("GAAP") recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission ("SEC") under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund's financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund's investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

**Level 1**—unadjusted quoted prices in active markets for identical investments.

**Level 2**—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

**Level 3**—significant unobservable inputs (including the fund's own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund's investments are as follows:

The Trust's Board of Trustees (the "Board") has designated the Adviser as the fund's valuation designee to make all fair value determinations with respect to the fund's portfolio investments, subject to the Board's oversight and pursuant to Rule 2a-5 under the Act.

Investments in equity securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. These securities are generally categorized within Level 2 of the fair value hierarchy.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depositary Receipts and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded, but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board. Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

Investments denominated in foreign currencies are translated to U.S. dollars at the prevailing rates of exchange.

**7**

------

Pursuant to a securities lending agreement with BNY, the fund may lend securities to qualified institutions. It is the fund's policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by the Adviser, or U.S. Government and Agency securities. The securities on loan, if any, are also disclosed in the fund's Statement of Investments. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to income earned as a result of the lending transaction. Should a borrower fail to return the securities in a timely manner, BNY is required to replace the securities for the benefit of the fund or credit the fund with the market value of the unreturned securities and is subrogated to the fund's rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis.

At July 31, 2025, accumulated net unrealized appreciation on investments was $27,731,970, consisting of $32,339,376 gross unrealized appreciation and $4,607,406 gross unrealized depreciation.

At July 31, 2025, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.

**8**

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** BNY Mellon Investment Funds III

- **b. Investment Company Act file number:** 811-00524

- **c. CIK number of Registrant:** 0000053808

- **d. LEI of Registrant:** 549300DOYFL5R4I71F16

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 240 Greenwich Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10286

  - **Telephone number:** 212-922-6400

**Item A.2. Information about the Series.**

- **a. Name of Series:** BNY Mellon Global Equity Income Fund

- **b. EDGAR series identifier (if any):** S000018029

- **c. LEI of Series:** 549300YDM1PXRAWO0B11

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-10-31

- **b. Date as of which information is reported:** 2025-07-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $195805130.45

**Total Liabilities:** $471513.07

**Net Assets:** $195333617.38

**Cash Not Reported:** $293789.67

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000130468 | 4.32%                | 2.33%                | -0.23%               |
| Class ID C000049947 | 4.31%                | 2.32%                | -0.23%               |
| Class ID C000049946 | 4.24%                | 2.28%                | -0.33%               |
| Class ID C000049945 | 4.26%                | 2.35%                | -0.28%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $885016.88               | $6237726.68                                |
| Month 2  | $1976977.53              | $1950837.61                                |
| Month 3  | $1316887.97              | $-1916219.71                               |

### Schedule of Portfolio Investments

| Name                           | Title                                                             | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Veolia Environnement SA        | Veolia Environnement SA                                           | CUSIP: 000000000<br>LEI: 969500LENY69X51OOT31 | Long             | EC               | CORP              | FR        |    106942 | NS      | $3624653.65   | 1.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Samsung Electronics Co Ltd     | Samsung Electronics Co Ltd                                        | CUSIP: 000000000<br>LEI: 9884007ER46L6N7EI764 | Long             | EP               | CORP              | KR        |    100918 | NS      | $4191575.43   | 2.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Sysco Corp                     | Sysco Corp                                                        | CUSIP: 871829107<br>LEI: 5RGWIFLMGH3YS7KWI652 | Long             | EC               | CORP              | US        |     45015 | NS      | $3583194.00   | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                | AstraZeneca PLC                                                   | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |     29742 | NS      | $4447928.18   | 2.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Deutsche Post AG               | Deutsche Post AG                                                  | CUSIP: 000000000<br>LEI: 8ER8GIG7CSMVD8VUFE78 | Long             | EC               | CORP              | DE        |     73866 | NS      | $3325472.43   | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Starbucks Corp                 | Starbucks Corp                                                    | CUSIP: 855244109<br>LEI: OQSJ1DU9TAOC51A47K68 | Long             | EC               | CORP              | US        |     46734 | NS      | $4166803.44   | 2.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc            | Gilead Sciences Inc                                               | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |     27426 | NS      | $3079665.54   | 1.58%             |  |  |  | No            |                  1 | On Loan: No      |
| CH Robinson Worldwide Inc      | CH Robinson Worldwide Inc                                         | CUSIP: 12541W209<br>LEI: 529900WNWN5L0OVDHA79 | Long             | EC               | CORP              | US        |     34645 | NS      | $3995261.40   | 2.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Universal Music Group NV       | Universal Music Group NV                                          | CUSIP: 000000000<br>LEI: 724500GJBUL3D9TW9Y18 | Long             | EC               | CORP              | NL        |    127871 | NS      | $3703611.66   | 1.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Tokyo Electron Ltd             | Tokyo Electron Ltd                                                | CUSIP: 000000000<br>LEI: 549300H5LSF8DP3RIJ34 | Long             | EC               | CORP              | JP        |     19100 | NS      | $3461558.36   | 1.77%             |  |  |  | No            |                  1 | On Loan: No      |
| HKEX                           | Hong Kong Exchanges & Clearing Ltd                                | CUSIP: 000000000<br>LEI: 213800YTVSXYQN17BW16 | Long             | EC               | CORP              | HK        |     49700 | NS      | $2703426.75   | 1.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Phillips 66                    | Phillips 66                                                       | CUSIP: 718546104<br>LEI: 5493005JBO5YSIGK1814 | Long             | EC               | CORP              | US        |     35290 | NS      | $4361138.20   | 2.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Publicis Groupe SA             | Publicis Groupe SA                                                | CUSIP: 000000000<br>LEI: 2138004KW8BV57III342 | Long             | EC               | CORP              | FR        |     35629 | NS      | $3260917.15   | 1.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Siemens AG                     | Siemens AG                                                        | CUSIP: 000000000<br>LEI: W38RGI023J3WT1HWRP32 | Long             | EC               | CORP              | DE        |     13452 | NS      | $3452534.90   | 1.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Kenvue Inc                     | Kenvue Inc                                                        | CUSIP: 49177J102<br>LEI: 5493008HSF8L4M2LIJ82 | Long             | EC               | CORP              | US        |    151738 | NS      | $3253262.72   | 1.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Expand Energy Corp             | Expand Energy Corp                                                | CUSIP: 165167735<br>LEI: X2MT1W32SPAZ9WSKLE78 | Long             | EC               | CORP              | US        |     24389 | NS      | $2555479.42   | 1.31%             |  |  |  | No            |                  1 | On Loan: No      |
| GSK PLC                        | GSK PLC                                                           | CUSIP: 000000000<br>LEI: 5493000HZTVUYLO1D793 | Long             | EC               | CORP              | GB        |    201139 | NS      | $3766693.24   | 1.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelon Corp                    | Exelon Corp                                                       | CUSIP: 30161N101<br>LEI: 3SOUA6IRML7435B56G12 | Long             | EC               | CORP              | US        |     90636 | NS      | $4073181.84   | 2.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Bank Mandiri Persero Tbk PT    | Bank Mandiri Persero Tbk PT                                       | CUSIP: 000000000<br>LEI: 549300RSKQN4Z5ZSGH94 | Long             | EC               | CORP              | ID        |   5377700 | NS      | $1473924.46   | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Cisco Systems Inc              | Cisco Systems Inc                                                 | CUSIP: 17275R102<br>LEI: 549300LKFJ962MZ46593 | Long             | EC               | CORP              | US        |     82490 | NS      | $5615919.20   | 2.88%             |  |  |  | No            |                  1 | On Loan: No      |
| First Horizon Corp             | First Horizon Corp                                                | CUSIP: 320517105<br>LEI: TF3RXI1ZB1TQ30H9JV10 | Long             | EC               | CORP              | US        |    139791 | NS      | $3048841.71   | 1.56%             |  |  |  | No            |                  1 | On Loan: No      |
| PepsiCo Inc                    | PepsiCo Inc                                                       | CUSIP: 713448108<br>LEI: FJSUNZKFNQ5YPJ5OT455 | Long             | EC               | CORP              | US        |     30272 | NS      | $4175114.24   | 2.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Wal-Mart de Mexico SAB de CV   | Wal-Mart de Mexico SAB de CV                                      | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | MX        |    894031 | NS      | $2634938.97   | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| BAE Systems PLC                | BAE Systems PLC                                                   | CUSIP: 000000000<br>LEI: 8SVCSVKSGDWMW2QHOH83 | Long             | EC               | CORP              | GB        |    157789 | NS      | $3759248.13   | 1.92%             |  |  |  | No            |                  1 | On Loan: No      |
| CME Group Inc                  | CME Group Inc                                                     | CUSIP: 12572Q105<br>LEI: LCZ7XYGSLJUHFXXNXD88 | Long             | EC               | CORP              | US        |     24984 | NS      | $6952547.52   | 3.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Shenzhen Mindray Bio-Medical E | Shenzhen Mindray Bio-Medical Electronics Co Ltd                   | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | CN        |     96900 | NS      | $3114638.05   | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Molson Coors Beverage Co       | Molson Coors Beverage Co                                          | CUSIP: 60871R209<br>LEI: 54930073LBBH6ZCBE225 | Long             | EC               | CORP              | US        |     71336 | NS      | $3475489.92   | 1.78%             |  |  |  | No            |                  1 | On Loan: No      |
| NARI Technology Co Ltd         | NARI Technology Co Ltd                                            | CUSIP: 000000000<br>LEI: 3003006IGH1W58MAQM05 | Long             | EC               | CORP              | CN        |    945700 | NS      | $2876713.98   | 1.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Industria de Diseno Textil SA  | Industria de Diseno Textil SA                                     | CUSIP: 000000000<br>LEI: 549300TTCXZOGZM2EY83 | Long             | EC               | CORP              | ES        |     99623 | NS      | $4764738.16   | 2.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi SA                      | Sanofi SA                                                         | CUSIP: 000000000<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |     46517 | NS      | $4185237.20   | 2.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Munich Re                      | Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen         | CUSIP: 000000000<br>LEI: 529900MUF4C20K50JS49 | Long             | EC               | CORP              | DE        |      3765 | NS      | $2473133.32   | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Fortum Oyj                     | Fortum Oyj                                                        | CUSIP: 000000000<br>LEI: 635400IUIZZIUJSAMF76 | Long             | EC               | CORP              | FI        |    119740 | NS      | $2198654.86   | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson              | Johnson & Johnson                                                 | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     28347 | NS      | $4669884.78   | 2.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Barclays PLC                   | Barclays PLC                                                      | CUSIP: 000000000<br>LEI: 213800LBQA1Y9L22JB70 | Long             | EC               | CORP              | GB        |    666551 | NS      | $3268481.79   | 1.67%             |  |  |  | No            |                  1 | On Loan: No      |
| ASE Technology Holding Co Ltd  | ASE Technology Holding Co Ltd                                     | CUSIP: 000000000<br>LEI: 300300GO8QHPMV87NZ73 | Long             | EC               | CORP              | TW        |    477000 | NS      | $2437138.79   | 1.25%             |  |  |  | No            |                  1 | On Loan: No      |
| MetLife Inc                    | MetLife Inc                                                       | CUSIP: 59156R108<br>LEI: C4BXATY60WC6XEOZDX54 | Long             | EC               | CORP              | US        |     40183 | NS      | $3051898.85   | 1.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                  | Medtronic PLC                                                     | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |     58149 | NS      | $5247365.76   | 2.69%             |  |  |  | No            |                  1 | On Loan: No      |
| DREYFUS INSTITUTIONAL PREFERRE | DREYFUS INSTITUTIONAL PREFERRED GOVERNMENT PLUS MONEY MARKET FUND | CUSIP: 000000000<br>LEI: 549300RBWL04JG8SIX57 | Long             | STIV             | RF                | US        |   3893811 | NS      | $3893810.53   | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Deutsche Lufthansa AG          | Deutsche Lufthansa AG                                             | CUSIP: 000000000<br>LEI: 529900PH63HYJ86ASW55 | Long             | EC               | CORP              | DE        |    288060 | NS      | $2479969.84   | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| International Paper Co         | International Paper Co                                            | CUSIP: 460146103<br>LEI: 824LMFJDH41EY779Q875 | Long             | EC               | CORP              | US        |     67244 | NS      | $3142984.56   | 1.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Cie de Saint-Gobain SA         | Cie de Saint-Gobain SA                                            | CUSIP: 000000000<br>LEI: NFONVGN05Z0FMN5PEC35 | Long             | EC               | CORP              | FR        |     32976 | NS      | $3774510.78   | 1.93%             |  |  |  | No            |                  1 | On Loan: No      |
| AIA Group Ltd                  | AIA Group Ltd                                                     | CUSIP: 000000000<br>LEI: ZP5ILWVSYE4LJGMMVD57 | Long             | EC               | CORP              | HK        |    532600 | NS      | $4979979.62   | 2.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Fresenius SE & Co KGaA         | Fresenius SE & Co KGaA                                            | CUSIP: 000000000<br>LEI: XDFJ0CYCOO1FXRFTQS51 | Long             | EC               | CORP              | DE        |     74633 | NS      | $3575486.12   | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Smurfit WestRock PLC           | Smurfit WestRock PLC                                              | CUSIP: 000000000<br>LEI: 635400EGSEOPDW2EXS14 | Long             | EC               | CORP              | IE        |     66597 | NS      | $2955574.86   | 1.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Kraft Heinz Co/The             | Kraft Heinz Co/The                                                | CUSIP: 500754106<br>LEI: 9845007488EC87F5AF14 | Long             | EC               | CORP              | US        |     83996 | NS      | $2306530.16   | 1.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co        | Bristol-Myers Squibb Co                                           | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |     56442 | NS      | $2444503.02   | 1.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Estee Lauder Cos Inc/The       | Estee Lauder Cos Inc/The                                          | CUSIP: 518439104<br>LEI: 549300VFZ8XJ9NUPU221 | Long             | EC               | CORP              | US        |     31953 | NS      | $2982493.02   | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Enel SpA                       | Enel SpA                                                          | CUSIP: 000000000<br>LEI: WOCMU6HCI0OJWNPRZS33 | Long             | EC               | CORP              | IT        |    436203 | NS      | $3849447.68   | 1.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Omnicom Group Inc              | Omnicom Group Inc                                                 | CUSIP: 681919106<br>LEI: HKUPACFHSSASQK8HLS17 | Long             | EC               | CORP              | US        |     34526 | NS      | $2487598.30   | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc         | UnitedHealth Group Inc                                            | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |      8507 | NS      | $2123006.92   | 1.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Moncler SpA                    | Moncler SpA                                                       | CUSIP: 000000000<br>LEI: 815600EBD7FB00525B20 | Long             | EC               | CORP              | IT        |     29529 | NS      | $1581807.35   | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| B3 SA - Brasil Bolsa Balcao    | B3 SA - Brasil Bolsa Balcao                                       | CUSIP: 000000000<br>LEI: 4GTK5S46E6H318LMDS44 | Long             | EC               | CORP              | BR        |   1126766 | NS      | $2527378.26   | 1.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Diamondback Energy Inc         | Diamondback Energy Inc                                            | CUSIP: 25278X109<br>LEI: 549300R22LSX6OHWEN64 | Long             | EC               | CORP              | US        |     27984 | NS      | $4160101.44   | 2.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Sandvik AB                     | Sandvik AB                                                        | CUSIP: 000000000<br>LEI: 5299008ZUAXN43LVZF54 | Long             | EC               | CORP              | SE        |    130569 | NS      | $3190449.20   | 1.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Dominion Energy Inc            | Dominion Energy Inc                                               | CUSIP: 25746U109<br>LEI: ILUL7B6Z54MRYCF6H308 | Long             | EC               | CORP              | US        |     76400 | NS      | $4465580.00   | 2.29%             |  |  |  | No            |                  1 | On Loan: No      |
| SKF AB                         | SKF AB                                                            | CUSIP: 000000000<br>LEI: 549300B6HWYEE57O8J84 | Long             | EC               | CORP              | SE        |     75918 | NS      | $1773623.78   | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Bank Rakyat Indonesia Persero  | Bank Rakyat Indonesia Persero Tbk PT                              | CUSIP: 000000000<br>LEI: 254900HB6S4B12GBNP64 | Long             | EC               | CORP              | ID        |   4811000 | NS      | $1084704.35   | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-09-23

**Name of Applicant:** BNY Mellon Investment Funds III

**Signature:** James Windels

**Name of Signer:** James Windels

**Title:** Treasurer